RespireRx Pharmaceuticals Inc (RSPI)

[food4thought]

I guess I don't understand why Stoll does not come out and state just that.

This is my interpretation of "Not ready for prime time". We have spent a lot of time and money progressing to this stage of the game. It is not, I repeat not, all for naught. We have gathered priceless data and experience and have chosen a more lucrative and immediate path with our drug and do still hold hopes of one day introducing CX-717 into the ADHD market. Because of uncertainty in the ADHD arena we have chosen to inactivate our IND for ADHD at this time and pursue more aggresively the indication holding recent positive findings for RD.

Maybe I am an idiot, but I did not get that out of Stoll's conference call.

I so badly want to invest more money into this company by year's end, but I need to far better understand the reasons for which we are where we are in hopes to not repeat this monumental investment debacle with regards to my finacial future.